Contract with Customer, Liability, Noncurrent of ELITE PHARMACEUTICALS INC /NV/ from 31 Mar 2021 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Contract with Customer, Liability, Noncurrent in USD history and change rate from 31 Mar 2021 to 30 Jun 2024.
  • ELITE PHARMACEUTICALS INC /NV/ Contract with Customer, Liability, Noncurrent for the quarter ending 30 Jun 2024 was $2,222, a 86% decline year-over-year.
Source SEC data
View on sec.gov
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Contract with Customer, Liability, Noncurrent, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Contract with Customer, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $2,222 -$13,334 -86% 30 Jun 2024 10-Q 14 Aug 2024 2025 Q1
Q1 2024 $5,556 -$13,334 -71% 31 Mar 2024 10-K 30 Jun 2025 2025 FY
Q4 2023 $8,889 -$13,334 -60% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q3 2023 $12,222 -$13,334 -52% 30 Sep 2023 10-Q 14 Nov 2023 2024 Q2
Q2 2023 $15,556 -$13,333 -46% 30 Jun 2023 10-Q 14 Aug 2023 2024 Q1
Q1 2023 $18,890 -$13,336 -41% 31 Mar 2023 10-K 01 Jul 2024 2024 FY
Q4 2022 $22,223 -$13,336 -38% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 $25,556 30 Sep 2022 10-Q 14 Nov 2022 2023 Q2
Q2 2022 $28,889 30 Jun 2022 10-Q 15 Aug 2022 2023 Q1
Q1 2022 $32,226 -$13,332 -29% 31 Mar 2022 10-K 29 Jun 2023 2023 FY
Q4 2021 $35,559 31 Dec 2021 10-Q 14 Feb 2022 2022 Q3
Q1 2021 $45,558 31 Mar 2021 10-K 29 Jun 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.